FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL)
K Number: K232963
·
Decision Jun 7, 2024
Classifications
1
FEI Numbers
8
Registration Numbers
8
Same Product Code
20
Applicant Total
251
Review Days
260
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL)
- K Number
- K232963
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.1640
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- bioMerieux, Inc.
- Date Received
- September 21, 2023
- Decision Date
- June 7, 2024
- Product Code
- NGZ
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NGZ | Susceptibility Test Plate, Antifungal | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (NGZ), ordered by most recent decision date.
The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL
FDA 510(k)
FDA Class 2
·Microbiology
VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)
FDA 510(k)
FDA Class 2
·Microbiology
The Sensititre YeastOne Susceptibility System with Rezafungin in the dilution range of 0.008-8ug/mL
FDA 510(k)
FDA Class 2
·Microbiology
Sensititre YeastOne Susceptibility System with Fluconazole in the dilution range of 0.12-128ug/mL
FDA 510(k)
FDA Class 2
·Microbiology
The Sensititre YeastOne Susceptibility System with Caspofungin in the dilution range of 0.015-16ug/ml
FDA 510(k)
FDA Class 2
·Microbiology
Sensititre YeastOne Susceptibility System with Voriconazole in the dilution range of 0.008 - 8 ug/mL
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by bioMerieux, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K260282 | VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance | Apr 15, 2026 | Substantially Equivalent |
| K251579 | VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) | Aug 21, 2025 | Substantially Equivalent |
| K234012 | VITEK COMPACT PRO | Mar 14, 2025 | Substantially Equivalent |
| K232967 | VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL) | Jun 12, 2024 | Substantially Equivalent |
| K240279 | VIDAS TBI (GFAP, UCH-L1) | May 1, 2024 | Substantially Equivalent |
| K234000 | VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL) | Mar 11, 2024 | Substantially Equivalent |
| K232201 | VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus Penicillin (<=0.06 - >=8 µg/mL), VITEK 2 Streptococcus Penicillin | Oct 23, 2023 | Substantially Equivalent |
| K230864 | VITEK 2 AST-Gram Positive Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin | Jul 5, 2023 | Substantially Equivalent |
| K222378 | VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL) | Jun 26, 2023 | Substantially Equivalent |
| K223478 | VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin | Feb 16, 2023 | Substantially Equivalent |